“The humanitarian crisis many feared would take place in March 2003 as a result of the war in Iraq appears to be unfolding,” says a new report (pdf) from the Congressional Research Service.
“It is estimated that in total (including those displaced prior to the war) there may be two million Iraqi refugees who have fled to Jordan, Syria, and other neighboring states, and approximately two million Iraqis who have been displaced within Iraq itself.” See “Iraqi Refugees and Internally Displaced Persons: A Deepening Humanitarian Crisis?,” March 23, 2007.
Another Congressional Research Service report provides a detailed examination of the pending defense supplemental appropriations bills, which include congressional direction on redeployment or withdrawal of U.S. troops from Iraq. See “FY2007 Supplemental Appropriations for Defense, Foreign Affairs, and Other Purposes” (pdf), updated March 28, 2007.
Other recent CRS products which have not been made readily available to the public include the following (all pdf).
“V-22 Osprey Tilt-Rotor Aircraft,” updated March 13, 2007.
“U.S. Assistance to the Former Soviet Union,” updated March 1, 2007.
“Nuclear Power: Outlook for New U.S. Reactors,” updated March 9, 2007.
“Military Medical Care: Questions and Answers,” updated March 7, 2007.
“Military Construction, Military Quality of Life and Veterans Affairs: FY2007 Appropriations,” updated March 6, 2007.
“U.S. International HIV/AIDS, Tuberculosis, and Malaria Spending: FY2004-FY2008,” updated March 6, 2007.
FAS commends the Senate Committee on Energy and Natural Resources for clearing a historic 75 pieces of legislation, including multiple crucial bills to confront the wildfire crisis.
The United States needs a strategic investment fund (SIF) to shepherd promising technologies in nationally vital sectors through the valley of death.
Standardizing support for Accessibility & Accommodations in federally funded research efforts would open opportunities for disabled scientists and their research programs.
The incoming administration must act to address bias in medical technology at the development, testing and regulation, and market-deployment and evaluation phases.